Is There a Cardiovascular Rationale for the Use of Combined Vasopressin V1a/V2 Receptor Antagonists?

Steven R. Goldsmith

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Is There a Cardiovascular Rationale for the Use of Combined Vasopressin V1a/V2 Receptor Antagonists?'. Together they form a unique fingerprint.

Medicine & Life Sciences